| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |